Raymond James Reiterates Strong Buy Rating on Liquidia Technologies (LQDA)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
LifeSci Capital Reiterates Outperform Rating on Liquidia Technologies (LQDA)
October 8, 2024 6:09 AM EDTLifeSci Capital analyst Cory Jubinville reiterated an Outperform rating and $30.00 price target on Liquidia Technologies (NASDAQ: LQDA)
The analyst comments "As we highlighted in our recent initiation (link here), the commercial launch of Liquidias (Nasdaq: LQDA) Yutrepia has been held back due to patent suits brought forward by United Therapeutics (Nasdaq: UTHR) regarding two key patents: 793 and 327. The 793 patent had previously been deemed invalid by the Federal Circuit for... More
BTIG Reiterates Buy Rating on Liquidia Technologies (LQDA)
October 7, 2024 1:01 PM EDTBTIG analyst Julian Harrison reiterated a Buy rating and $25.00 price target on Liquidia Technologies (NASDAQ: LQDA).
The analyst comments "As we expected, the Supreme Court of the United States has denied UTHR's (Neutral) writ of certiorari request to challenge the prior invalidation of... More
